Consolidated Statement of Cash Flows (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Feb. 28, 2023	Feb. 28, 2022
Cash flows from operating activities:
Net income (loss)	$ 1,074,964	$ 670,839
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation and amortization	265,873	265,161
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions	(51,267)	(112,641)
Provision for current expected credit losses	(15,555)	11,562
Deferred taxes	(16,522)	4,301
Other, net	(496)	(7,092)
Changes in operating assets and liabilities, net of acquisitions:
Receivables	(52,159)	(591,106)
Inventories	(1,205,388)	(1,970,142)
Accounts payable and accrued expenses	(97,026)	511,223
Other liabilities	114,146	(85,646)
Net cash provided by (used in) operating activities	16,570	(1,303,541)
Cash flows from investing activities:
Acquisition of property, plant and equipment	(236,290)	(130,884)
Proceeds from disposition of property, plant and equipment	12,642	6,140
Expenditures for major repairs	(39,400)	(8,318)
Proceeds from Sales of Business, Affiliate and Productive Assets	64	55,546
Changes in CHS Capital notes receivable, net	(171,937)	(82,384)
Financing extended to customers	(76,142)	(30,474)
Payments from customer financing	86,678	33,310
Other investing activities, net	(9,102)	924
Net cash provided by (used in) investing activities	(433,487)	(156,140)
Cash flows from financing activities:
Proceeds from lines of credit and long-term borrowings	4,887,148	12,322,409
Payments on lines of credit, long-term borrowings and capital lease obligations	(4,288,434)	(11,008,138)
Preferred stock dividends paid	(84,334)	(84,334)
Redemptions of equities	(17,746)	(17,485)
Cash patronage dividends paid	(381,890)	(30,043)
Other financing activities, net	(11,242)	9,257
Net cash provided by (used in) financing activities	103,502	1,191,666
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	(205)	(3,717)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	(313,620)	(271,732)
Cash and cash equivalents and restricted cash at beginning of period	903,474	542,484
Cash and cash equivalents and restricted cash at end of period	$ 589,854	$ 270,752